Vespa crabro chromosome 15, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342414.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitochondrial folate transporter/carrier, transcript variant X4
mitochondrial folate transporter/carrier, transcript variant X6
mitochondrial folate transporter/carrier, transcript variant X5
mitochondrial folate transporter/carrier, transcript variant X3
mitochondrial folate transporter/carrier, transcript variant X10
mitochondrial folate transporter/carrier, transcript variant X9
mitochondrial folate transporter/carrier, transcript variant X8
mitochondrial folate transporter/carrier, transcript variant X7
mitochondrial folate transporter/carrier, transcript variant X11
mitochondrial folate transporter/carrier, transcript variant X1
mitochondrial folate transporter/carrier, transcript variant X2
mitochondrial folate transporter/carrier
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
uncharacterized LOC124429364, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124429364, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC124429364 isoform X1
uncharacterized protein LOC124429364 isoform X2
acetylcholine receptor subunit alpha-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 242 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
acetylcholine receptor subunit alpha-like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 242 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
acetylcholine receptor subunit alpha-like 1
acetylcholine receptor subunit alpha-L1, transcript variant X2
acetylcholine receptor subunit alpha-L1, transcript variant X1
acetylcholine receptor subunit alpha-L1 isoform X1
acetylcholine receptor subunit alpha-L1 isoform X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
arylalkylamine N-acetyltransferase 1-like, transcript variant X1
arylalkylamine N-acetyltransferase 1-like isoform X1
arylalkylamine N-acetyltransferase 1-like, transcript variant X2
arylalkylamine N-acetyltransferase 1-like isoform X2
uncharacterized LOC124429595, transcript variant X1
uncharacterized protein LOC124429595 isoform X1
uncharacterized LOC124429595, transcript variant X2
uncharacterized protein LOC124429595 isoform X2
eukaryotic translation initiation factor 5
kinesin light chain, transcript variant X10
kinesin light chain, transcript variant X9
kinesin light chain, transcript variant X8
kinesin light chain, transcript variant X17
kinesin light chain, transcript variant X6
kinesin light chain, transcript variant X13
kinesin light chain, transcript variant X7
kinesin light chain, transcript variant X4
kinesin light chain, transcript variant X2
kinesin light chain, transcript variant X3
kinesin light chain, transcript variant X1
kinesin light chain, transcript variant X5
kinesin light chain, transcript variant X15
kinesin light chain, transcript variant X16
kinesin light chain, transcript variant X12
kinesin light chain, transcript variant X14
kinesin light chain, transcript variant X11
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X2
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X1
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X3
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X1
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X2
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X5
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X4
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X4
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X3
adenosine 3'-phospho 5'-phosphosulfate transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized aarF domain-containing protein kinase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
ecdysone 20-monooxygenase, transcript variant X4
ecdysone 20-monooxygenase, transcript variant X3
ecdysone 20-monooxygenase, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X10
ecdysone 20-monooxygenase, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X6
ecdysone 20-monooxygenase, transcript variant X8
ecdysone 20-monooxygenase, transcript variant X5
ecdysone 20-monooxygenase, transcript variant X7
ecdysone 20-monooxygenase, transcript variant X2
uncharacterized LOC124429608, transcript variant X4
uncharacterized LOC124429608, transcript variant X3
uncharacterized LOC124429608, transcript variant X1
uncharacterized LOC124429608, transcript variant X2
uncharacterized protein LOC124429608 isoform X3
uncharacterized protein LOC124429608 isoform X2
uncharacterized protein LOC124429608 isoform X1
cyclin-dependent kinase 8, transcript variant X2
cyclin-dependent kinase 8, transcript variant X1
cyclin-dependent kinase 8, transcript variant X3
uridine phosphorylase 1, transcript variant X3
uridine phosphorylase 1, transcript variant X1
uridine phosphorylase 1, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 1 isoform X1
ubiquitin carboxyl-terminal hydrolase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124429394, transcript variant X1
uncharacterized LOC124429394, transcript variant X2
uncharacterized protein LOC124429394 isoform X1
uncharacterized protein LOC124429394 isoform X2
protein bric-a-brac 1-like, transcript variant X2
protein bric-a-brac 1-like, transcript variant X3
protein bric-a-brac 1-like, transcript variant X1
MAGUK p55 subfamily member 7, transcript variant X1
MAGUK p55 subfamily member 7, transcript variant X3
MAGUK p55 subfamily member 7, transcript variant X2
MAGUK p55 subfamily member 7, transcript variant X4
venom protease-like, transcript variant X1
venom protease-like, transcript variant X2
venom protease-like, transcript variant X4
venom protease-like, transcript variant X3
heterogeneous nuclear ribonucleoprotein R, transcript variant X6
heterogeneous nuclear ribonucleoprotein R, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X10
heterogeneous nuclear ribonucleoprotein R, transcript variant X8
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X5
heterogeneous nuclear ribonucleoprotein R, transcript variant X11
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X13
heterogeneous nuclear ribonucleoprotein R, transcript variant X9
heterogeneous nuclear ribonucleoprotein R, transcript variant X3
heterogeneous nuclear ribonucleoprotein R, transcript variant X4
heterogeneous nuclear ribonucleoprotein R, transcript variant X7
heterogeneous nuclear ribonucleoprotein R isoform X2
heterogeneous nuclear ribonucleoprotein R isoform X6
heterogeneous nuclear ribonucleoprotein R isoform X7
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R isoform X3
heterogeneous nuclear ribonucleoprotein R isoform X4
heterogeneous nuclear ribonucleoprotein R isoform X5
bone morphogenetic protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
dorsal-ventral patterning tolloid-like protein 1 isoform X3
uncharacterized LOC124429399, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC124429399, transcript variant X1
uncharacterized protein LOC124429399 isoform X1
uncharacterized protein LOC124429399 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vacuolar protein sorting-associated protein 16 homolog
phosphopantothenate--cysteine ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
phosphopantothenate--cysteine ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tyrosine-protein kinase Fer, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tyrosine-protein kinase Fer, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tyrosine-protein kinase Fer, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tyrosine-protein kinase Fer, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pescadillo homolog, transcript variant X3
translation initiation factor eIF-2B subunit alpha, transcript variant X1
translation initiation factor eIF-2B subunit alpha, transcript variant X2
translation initiation factor eIF-2B subunit alpha isoform X1
translation initiation factor eIF-2B subunit alpha isoform X2
pescadillo homolog, transcript variant X1
pescadillo homolog, transcript variant X2
ecdysone-induced protein 74EF-like, transcript variant X2
ecdysone-induced protein 74EF-like, transcript variant X1
ecdysone-induced protein 74EF-like, transcript variant X3
ecdysone-induced protein 74EF-like, transcript variant X4
ecdysone-induced protein 74EF-like, transcript variant X6
ecdysone-induced protein 74EF-like, transcript variant X5
ecdysone-induced protein 74EF-like isoform X2
ecdysone-induced protein 74EF-like isoform X1
ecdysone-induced protein 74EF-like isoform X3
U7 snRNA-associated Sm-like protein LSm11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
high affinity copper uptake protein 1, transcript variant X2
high affinity copper uptake protein 1, transcript variant X1
high affinity copper uptake protein 1 isoform X1
high affinity copper uptake protein 1 isoform X2
ras-related protein Rab-9A, transcript variant X2
ras-related protein Rab-9A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial mRNA pseudouridine synthase Trub2
14 kDa phosphohistidine phosphatase-like
phosrestin-2-like, transcript variant X4
phosrestin-2-like, transcript variant X3
phosrestin-2-like, transcript variant X1
phosrestin-2-like, transcript variant X2
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X1
RNA pseudouridylate synthase domain-containing protein 2-like isoform X1
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X2
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X4
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X3
RNA pseudouridylate synthase domain-containing protein 2-like isoform X2
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial
BMP-binding endothelial regulator protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate receptor ionotropic, delta-1-like
putative inorganic phosphate cotransporter, transcript variant X2
putative inorganic phosphate cotransporter isoform X2
putative inorganic phosphate cotransporter, transcript variant X1
putative inorganic phosphate cotransporter isoform X1
T-cell immunomodulatory protein, transcript variant X2
T-cell immunomodulatory protein, transcript variant X1
26S proteasome non-ATPase regulatory subunit 5
O-acyltransferase like protein, transcript variant X2
O-acyltransferase like protein, transcript variant X1
O-acyltransferase like protein, transcript variant X4
O-acyltransferase like protein, transcript variant X3
O-acyltransferase like protein isoform X4
O-acyltransferase like protein isoform X3
O-acyltransferase like protein isoform X2
O-acyltransferase like protein isoform X1
deoxynucleotidyltransferase terminal-interacting protein 2, transcript variant X1
deoxynucleotidyltransferase terminal-interacting protein 2 isoform X1
deoxynucleotidyltransferase terminal-interacting protein 2, transcript variant X2
deoxynucleotidyltransferase terminal-interacting protein 2 isoform X2
raf homolog serine/threonine-protein kinase Raf
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X1
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X5
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X2
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X3
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X4
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X6
MATH and LRR domain-containing protein PFE0570w-like isoform X2
uncharacterized protein LOC124429342 isoform X1
myotubularin-related protein 2, transcript variant X3
myotubularin-related protein 2, transcript variant X1
myotubularin-related protein 2, transcript variant X4
myotubularin-related protein 2, transcript variant X2
myotubularin-related protein 2 isoform X1
myotubularin-related protein 2 isoform X2
nose resistant to fluoxetine protein 6-like, transcript variant X2
nose resistant to fluoxetine protein 6-like, transcript variant X1
nose resistant to fluoxetine protein 6-like, transcript variant X3
nose resistant to fluoxetine protein 6-like isoform X2
nose resistant to fluoxetine protein 6-like isoform X1
uncharacterized LOC124429339, transcript variant X2
uncharacterized LOC124429339, transcript variant X4
uncharacterized LOC124429339, transcript variant X1
uncharacterized LOC124429339, transcript variant X3
uncharacterized protein LOC124429339 isoform X2
uncharacterized protein LOC124429339 isoform X1
uncharacterized protein LOC124429339 isoform X3
transmembrane protein 138, transcript variant X3
transmembrane protein 138, transcript variant X2
transmembrane protein 138, transcript variant X1
RNA polymerase II degradation factor 1-like, transcript variant X4
RNA polymerase II degradation factor 1-like, transcript variant X6
RNA polymerase II degradation factor 1-like, transcript variant X5
RNA polymerase II degradation factor 1-like, transcript variant X7
RNA polymerase II degradation factor 1-like, transcript variant X2
RNA polymerase II degradation factor 1-like, transcript variant X1
RNA polymerase II degradation factor 1-like, transcript variant X3
RNA polymerase II degradation factor 1-like, transcript variant X8
RNA polymerase II degradation factor 1-like, transcript variant X9
uncharacterized protein LOC124429347 isoform X2
RNA polymerase II degradation factor 1-like isoform X3
uncharacterized protein LOC124429347 isoform X1
uncharacterized protein LOC124429347 isoform X4
uncharacterized protein LOC124429347 isoform X5
dynein axonemal intermediate chain 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase RNF185-like, transcript variant X3
E3 ubiquitin-protein ligase RNF185-like, transcript variant X2
E3 ubiquitin-protein ligase RNF185-like, transcript variant X4
E3 ubiquitin-protein ligase RNF185-like, transcript variant X1
ubiquitin-protein ligase E3B, transcript variant X4
ubiquitin-protein ligase E3B, transcript variant X3
ubiquitin-protein ligase E3B, transcript variant X1
ubiquitin-protein ligase E3B, transcript variant X2
serine/threonine-protein kinase NLK, transcript variant X1
serine/threonine-protein kinase NLK, transcript variant X2
NAD(+) hydrolase sarm1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
NAD(+) hydrolase sarm1, transcript variant X8
NAD(+) hydrolase sarm1, transcript variant X3
NAD(+) hydrolase sarm1, transcript variant X1
NAD(+) hydrolase sarm1, transcript variant X7
NAD(+) hydrolase sarm1, transcript variant X2
NAD(+) hydrolase sarm1, transcript variant X5
NAD(+) hydrolase sarm1, transcript variant X6
NAD(+) hydrolase sarm1, transcript variant X9
myeloid differentiation primary response protein MyD88-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
CAP-Gly domain-containing linker protein 1, transcript variant X1
CAP-Gly domain-containing linker protein 1, transcript variant X8
CAP-Gly domain-containing linker protein 1, transcript variant X3
CAP-Gly domain-containing linker protein 1, transcript variant X2
CAP-Gly domain-containing linker protein 1, transcript variant X4
CAP-Gly domain-containing linker protein 1, transcript variant X5
CAP-Gly domain-containing linker protein 1, transcript variant X7
CAP-Gly domain-containing linker protein 1, transcript variant X6
CAP-Gly domain-containing linker protein 1 isoform X7
DNA-directed RNA polymerase II subunit RPB11, transcript variant X3
DNA-directed RNA polymerase II subunit RPB11, transcript variant X2
DNA-directed RNA polymerase II subunit RPB11, transcript variant X1
DNA-directed RNA polymerase II subunit RPB11 isoform X1
DNA-directed RNA polymerase II subunit RPB11 isoform X3
DNA-directed RNA polymerase II subunit RPB11 isoform X2
mitogen-activated protein kinase 1, transcript variant X6
mitogen-activated protein kinase 1, transcript variant X5
mitogen-activated protein kinase 1, transcript variant X4
mitogen-activated protein kinase 1, transcript variant X3
mitogen-activated protein kinase 1, transcript variant X2
mitogen-activated protein kinase 1, transcript variant X1
stress-activated protein kinase JNK, transcript variant X5
stress-activated protein kinase JNK, transcript variant X4
stress-activated protein kinase JNK, transcript variant X7
stress-activated protein kinase JNK, transcript variant X3
stress-activated protein kinase JNK, transcript variant X1
stress-activated protein kinase JNK, transcript variant X6
stress-activated protein kinase JNK, transcript variant X2
stress-activated protein kinase JNK, transcript variant X8
stress-activated protein kinase JNK isoform X1
stress-activated protein kinase JNK isoform X2
myeloid differentiation primary response protein MyD88-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X1
protein bicaudal C, transcript variant X5
protein bicaudal C, transcript variant X6
protein bicaudal C, transcript variant X4
protein bicaudal C, transcript variant X1
protein bicaudal C, transcript variant X3
protein bicaudal C, transcript variant X2
protein bicaudal C, transcript variant X7
protein bicaudal C, transcript variant X8
N6-adenosine-methyltransferase non-catalytic subunit
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X3
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X1
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X3
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1
outer mitochondrial transmembrane helix translocase-like, transcript variant X2
outer mitochondrial transmembrane helix translocase-like, transcript variant X1
outer mitochondrial transmembrane helix translocase-like
uncharacterized LOC124429653, transcript variant X2
uncharacterized LOC124429653, transcript variant X1
uncharacterized LOC124429653, transcript variant X3
uncharacterized LOC124429401, transcript variant X1
uncharacterized LOC124429401, transcript variant X2
uncharacterized LOC124429401, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like, transcript variant X1
proto-oncogene tyrosine-protein kinase receptor Ret, transcript variant X1
proto-oncogene tyrosine-protein kinase receptor Ret, transcript variant X2
proto-oncogene tyrosine-protein kinase receptor Ret isoform X1
proto-oncogene tyrosine-protein kinase receptor Ret isoform X2
uncharacterized LOC124429309, transcript variant X1
uncharacterized LOC124429309, transcript variant X2
uncharacterized protein LOC124429309 isoform X1
uncharacterized protein LOC124429309 isoform X2
homogentisate 1,2-dioxygenase, transcript variant X2
homogentisate 1,2-dioxygenase, transcript variant X1
homogentisate 1,2-dioxygenase isoform X1
homogentisate 1,2-dioxygenase isoform X2
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X1
MATH and LRR domain-containing protein PFE0570w-like isoform X1
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X3
putative mediator of RNA polymerase II transcription subunit 26 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like, transcript variant X1
pancreatic triacylglycerol lipase-like, transcript variant X2
pancreatic triacylglycerol lipase-like isoform X1
pancreatic triacylglycerol lipase-like isoform X2
uncharacterized LOC124429641, transcript variant X3
uncharacterized LOC124429641, transcript variant X2
uncharacterized LOC124429641, transcript variant X1
prostaglandin E synthase 3, transcript variant X2
prostaglandin E synthase 3, transcript variant X1
prostaglandin E synthase 3, transcript variant X3
INO80 complex subunit C, transcript variant X3
INO80 complex subunit C, transcript variant X4
INO80 complex subunit C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
INO80 complex subunit C, transcript variant X1
INO80 complex subunit C, transcript variant X5
uncharacterized protein LOC124429667 isoform X1
uncharacterized protein LOC124429667 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
39S ribosomal protein L20, mitochondrial
10 kDa heat shock protein, mitochondrial
uncharacterized LOC124429332, transcript variant X2
uncharacterized LOC124429332, transcript variant X1
uncharacterized protein LOC124429332 isoform X2
uncharacterized protein LOC124429332 isoform X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X6
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X2
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X7
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X4
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X3
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X5
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X3
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X2
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 1-like isoform X2
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X3
solute carrier family 2, facilitated glucose transporter member 1-like isoform X3
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 1-like isoform X1
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X4
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X5
solute carrier family 2, facilitated glucose transporter member 1-like isoform X4
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X6
solute carrier family 2, facilitated glucose transporter member 1-like isoform X5
protein PF14_0175-like, transcript variant X2
protein PF14_0175-like, transcript variant X1
PP2C-like domain-containing protein CG9801, transcript variant X2
PP2C-like domain-containing protein CG9801, transcript variant X1
PP2C-like domain-containing protein CG9801, transcript variant X3
PP2C-like domain-containing protein CG9801 isoform X2
PP2C-like domain-containing protein CG9801 isoform X1
protein zyg-11 homolog B-like, transcript variant X1
protein zyg-11 homolog B-like, transcript variant X3
protein zyg-11 homolog B-like, transcript variant X2
polyadenylate-binding protein 2, transcript variant X2
polyadenylate-binding protein 2, transcript variant X1
defective pharyngeal development protein 4-like, transcript variant X1
defective pharyngeal development protein 4-like, transcript variant X2
defective pharyngeal development protein 4-like isoform X1
uncharacterized protein LOC124429355 isoform X2
neural/ectodermal development factor IMP-L2, transcript variant X3
neural/ectodermal development factor IMP-L2, transcript variant X2
neural/ectodermal development factor IMP-L2, transcript variant X1
neural/ectodermal development factor IMP-L2 isoform X3
neural/ectodermal development factor IMP-L2 isoform X2
neural/ectodermal development factor IMP-L2 isoform X1
GTP-binding protein 2, transcript variant X1
GTP-binding protein 2, transcript variant X2
uncharacterized protein C16C10.8, transcript variant X2
uncharacterized protein C16C10.8, transcript variant X1
uncharacterized protein C16C10.8 isoform X1
cell growth-regulating nucleolar protein isoform X2
nuclear RNA export factor 1-like, transcript variant X2
nuclear RNA export factor 1-like, transcript variant X1
nuclear RNA export factor 1-like isoform X2
nuclear RNA export factor 1-like isoform X1
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
H/ACA ribonucleoprotein complex non-core subunit NAF1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase U, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase U, transcript variant X2
receptor-type tyrosine-protein phosphatase U, transcript variant X3
receptor-type tyrosine-protein phosphatase mu isoform X1
receptor-type tyrosine-protein phosphatase U isoform X2
golgin subfamily A member 1, transcript variant X1
golgin subfamily A member 1, transcript variant X2
protein purity of essence, transcript variant X1
protein purity of essence, transcript variant X3
protein purity of essence, transcript variant X2
protein purity of essence, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
solute carrier family 35 member C2, transcript variant X3
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X2
probable cationic amino acid transporter, transcript variant X6
probable cationic amino acid transporter, transcript variant X5
probable cationic amino acid transporter, transcript variant X4
probable cationic amino acid transporter, transcript variant X3
probable cationic amino acid transporter, transcript variant X2
probable cationic amino acid transporter, transcript variant X1
probable cationic amino acid transporter, transcript variant X7
probable cationic amino acid transporter
tRNA modification GTPase MnmE, transcript variant X1
tRNA modification GTPase MnmE, transcript variant X2
tRNA modification GTPase MnmE isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
solute carrier family 22 member 21-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 22 member 21-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 22 member 21-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 22 member 21-like isoform X1
solute carrier family 22 member 21-like isoform X2
solute carrier family 22 member 21-like isoform X3
probable WRKY transcription factor protein 1, transcript variant X4
probable WRKY transcription factor protein 1, transcript variant X1
probable WRKY transcription factor protein 1, transcript variant X6
probable WRKY transcription factor protein 1, transcript variant X5
probable WRKY transcription factor protein 1, transcript variant X2
probable WRKY transcription factor protein 1, transcript variant X3
probable WRKY transcription factor protein 1 isoform X1
type-2 histone deacetylase 1-like isoform X3
probable WRKY transcription factor protein 1 isoform X2
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
transcription factor AP-1-like, transcript variant X1
transcription factor AP-1-like isoform X1
transcription factor AP-1-like, transcript variant X2
transcription factor AP-1-like isoform X2
long-chain fatty acid transport protein 4-like
long-chain fatty acid transport protein 4, transcript variant X2
long-chain fatty acid transport protein 4, transcript variant X1
long-chain fatty acid transport protein 4, transcript variant X3
long-chain fatty acid transport protein 4, transcript variant X4
long-chain fatty acid transport protein 4 isoform X1
long-chain fatty acid transport protein 4 isoform X2
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
translation initiation factor eIF-2B subunit gamma, transcript variant X2
translation initiation factor eIF-2B subunit gamma, transcript variant X3
translation initiation factor eIF-2B subunit gamma, transcript variant X1
translation initiation factor eIF-2B subunit gamma
protein RCC2 homolog, transcript variant X1
protein RCC2 homolog, transcript variant X2
protein RCC2 homolog, transcript variant X3
ras-related protein Rab-18-B, transcript variant X2
ras-related protein Rab-18-B, transcript variant X1
uncharacterized protein DDB_G0283357, transcript variant X5
uncharacterized protein DDB_G0283357, transcript variant X1
uncharacterized protein DDB_G0283357, transcript variant X3
uncharacterized protein DDB_G0283357, transcript variant X2
uncharacterized protein DDB_G0283357, transcript variant X4
uncharacterized protein DDB_G0283357 isoform X1
uncharacterized protein DDB_G0283357 isoform X2
pancreatic triacylglycerol lipase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like isoform X3
pancreatic triacylglycerol lipase-like, transcript variant X3
pancreatic lipase-related protein 2-like, transcript variant X3
pancreatic lipase-related protein 2-like, transcript variant X1
pancreatic lipase-related protein 2-like, transcript variant X2
pancreatic lipase-related protein 2-like isoform X2
pancreatic lipase-related protein 2-like isoform X1
polypyrimidine tract-binding protein 1, transcript variant X6
polypyrimidine tract-binding protein 1, transcript variant X9
polypyrimidine tract-binding protein 1, transcript variant X10
polypyrimidine tract-binding protein 1, transcript variant X14
polypyrimidine tract-binding protein 1, transcript variant X19
polypyrimidine tract-binding protein 1, transcript variant X5
polypyrimidine tract-binding protein 1, transcript variant X17
polypyrimidine tract-binding protein 1, transcript variant X15
polypyrimidine tract-binding protein 1 isoform X5
polypyrimidine tract-binding protein 1 isoform X8
polypyrimidine tract-binding protein 1 isoform X9
polypyrimidine tract-binding protein 1 isoform X13
polypyrimidine tract-binding protein 1 isoform X16
venom carboxylesterase-6-like, transcript variant X3
venom carboxylesterase-6-like, transcript variant X2
venom carboxylesterase-6-like, transcript variant X1
venom carboxylesterase-6-like isoform X1
venom carboxylesterase-6-like isoform X2
venom carboxylesterase-6-like isoform X3
polypyrimidine tract-binding protein 1, transcript variant X4
polypyrimidine tract-binding protein 1, transcript variant X11
polypyrimidine tract-binding protein 1, transcript variant X7
polypyrimidine tract-binding protein 1, transcript variant X8
polypyrimidine tract-binding protein 1, transcript variant X12
polypyrimidine tract-binding protein 1, transcript variant X18
polypyrimidine tract-binding protein 1 isoform X4
polypyrimidine tract-binding protein 1 isoform X10
polypyrimidine tract-binding protein 1 isoform X6
polypyrimidine tract-binding protein 1 isoform X7
polypyrimidine tract-binding protein 1 isoform X11
polypyrimidine tract-binding protein 1 isoform X15
polypyrimidine tract-binding protein 1, transcript variant X21
polypyrimidine tract-binding protein 1, transcript variant X16
polypyrimidine tract-binding protein 1, transcript variant X1
polypyrimidine tract-binding protein 1, transcript variant X2
polypyrimidine tract-binding protein 1, transcript variant X3
polypyrimidine tract-binding protein 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
polypyrimidine tract-binding protein 1 isoform X1
polypyrimidine tract-binding protein 1 isoform X2
polypyrimidine tract-binding protein 1 isoform X3
polypyrimidine tract-binding protein 1 isoform X14
polypyrimidine tract-binding protein 1, transcript variant X13
polypyrimidine tract-binding protein 1 isoform X12
cuticle protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cuticle protein 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pupal cuticle protein-like, transcript variant X4
pupal cuticle protein-like, transcript variant X2
pupal cuticle protein-like, transcript variant X1
pupal cuticle protein-like, transcript variant X3
xaa-Pro aminopeptidase 3, transcript variant X1
xaa-Pro aminopeptidase 3, transcript variant X2
multifunctional protein ADE2, transcript variant X2
multifunctional protein ADE2, transcript variant X1
amidophosphoribosyltransferase-like, transcript variant X2
amidophosphoribosyltransferase-like, transcript variant X3
amidophosphoribosyltransferase-like, transcript variant X1
amidophosphoribosyltransferase-like isoform X1
amidophosphoribosyltransferase-like isoform X2
amidophosphoribosyltransferase-like isoform X3
probable serine/threonine-protein kinase dyrk1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable serine/threonine-protein kinase dyrk1, transcript variant X1
probable serine/threonine-protein kinase dyrk1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
sterol regulatory element-binding protein 1
inositol-pentakisphosphate 2-kinase, transcript variant X1
inositol-pentakisphosphate 2-kinase, transcript variant X7
inositol-pentakisphosphate 2-kinase, transcript variant X2
inositol-pentakisphosphate 2-kinase, transcript variant X5
inositol-pentakisphosphate 2-kinase, transcript variant X4
inositol-pentakisphosphate 2-kinase, transcript variant X3
inositol-pentakisphosphate 2-kinase, transcript variant X6
uncharacterized LOC124429511, transcript variant X2
uncharacterized LOC124429511, transcript variant X3
uncharacterized LOC124429511, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124429496, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124429496, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124429496, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124429496, transcript variant X4
uncharacterized LOC124429496, transcript variant X2
uncharacterized protein LOC124429496 isoform X4
uncharacterized protein LOC124429496 isoform X3
uncharacterized protein LOC124429496 isoform X2
uncharacterized protein LOC124429496 isoform X1
uncharacterized LOC124429596, transcript variant X2
uncharacterized LOC124429596, transcript variant X7
uncharacterized LOC124429596, transcript variant X1
uncharacterized LOC124429596, transcript variant X4
uncharacterized LOC124429596, transcript variant X5
uncharacterized LOC124429596, transcript variant X3
uncharacterized protein LOC124429596 isoform X1
uncharacterized protein LOC124429596 isoform X2
uncharacterized protein LOC124429596 isoform X3
uncharacterized LOC124429596, transcript variant X6
uncharacterized protein LOC124429596 isoform X4
putative mediator of RNA polymerase II transcription subunit 26
acanthoscurrin-2-like, transcript variant X3
acanthoscurrin-2-like, transcript variant X2
acanthoscurrin-2-like, transcript variant X1
acanthoscurrin-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124429492, transcript variant X1
uncharacterized LOC124429492, transcript variant X2
uncharacterized LOC124429492, transcript variant X3
uncharacterized protein LOC124429492 isoform X1
uncharacterized protein LOC124429492 isoform X2
long-chain-fatty-acid--CoA ligase 4, transcript variant X16
long-chain-fatty-acid--CoA ligase 4, transcript variant X14
long-chain-fatty-acid--CoA ligase 4, transcript variant X12
long-chain-fatty-acid--CoA ligase 4, transcript variant X9
long-chain-fatty-acid--CoA ligase 4, transcript variant X11
long-chain-fatty-acid--CoA ligase 4, transcript variant X8
long-chain-fatty-acid--CoA ligase 4, transcript variant X10
long-chain-fatty-acid--CoA ligase 4, transcript variant X7
long-chain-fatty-acid--CoA ligase 4, transcript variant X15
long-chain-fatty-acid--CoA ligase 4, transcript variant X5
long-chain-fatty-acid--CoA ligase 4, transcript variant X6
long-chain-fatty-acid--CoA ligase 4, transcript variant X13
long-chain-fatty-acid--CoA ligase 4 isoform X4
long-chain-fatty-acid--CoA ligase 4 isoform X5
long-chain-fatty-acid--CoA ligase 4 isoform X6
long-chain-fatty-acid--CoA ligase 4, transcript variant X1
long-chain-fatty-acid--CoA ligase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC124429531 isoform X1
long-chain-fatty-acid--CoA ligase 4, transcript variant X4
tRNA-uridine aminocarboxypropyltransferase 1-like
uncharacterized protein LOC124429531 isoform X3
long-chain-fatty-acid--CoA ligase 4, transcript variant X2
uncharacterized protein LOC124429531 isoform X2
protein nessun dorma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein nessun dorma, transcript variant X1
ADP-ribosylation factor-like protein 2-binding protein, transcript variant X1
ADP-ribosylation factor-like protein 2-binding protein isoform X1
ADP-ribosylation factor-like protein 2-binding protein, transcript variant X2
ADP-ribosylation factor-like protein 2-binding protein, transcript variant X3
ADP-ribosylation factor-like protein 2-binding protein isoform X2
ADP-ribosylation factor-like protein 2-binding protein isoform X3
nuclear pore complex protein Nup93-like, transcript variant X1
nuclear pore complex protein Nup93-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X4
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X1
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X3
reticulocyte-binding protein homolog 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
reticulocyte-binding protein homolog 1-like, transcript variant X2
reticulocyte-binding protein homolog 1-like isoform X1
reticulocyte-binding protein homolog 1-like isoform X2
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X5
synaptonemal complex protein 1-like isoform X1
ELKS/Rab6-interacting/CAST family member 1-like isoform X3
COA8 family protein CG14806, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcription elongation regulator 1, transcript variant X5
transcription elongation regulator 1, transcript variant X6
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X7
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X5
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1, transcript variant X8
transcription elongation regulator 1 isoform X6
uncharacterized LOC124429632, transcript variant X1
uncharacterized LOC124429632, transcript variant X2
uncharacterized protein LOC124429632 isoform X1
uncharacterized protein LOC124429632 isoform X2
uncharacterized LOC124429632, transcript variant X3
uncharacterized LOC124429632, transcript variant X4
uncharacterized protein LOC124429632 isoform X3
DENN domain-containing protein 10-like, transcript variant X4
DENN domain-containing protein 10-like, transcript variant X1
DENN domain-containing protein 10-like, transcript variant X2
DENN domain-containing protein 10-like, transcript variant X3
probable serine/threonine-protein kinase clkA
uncharacterized LOC124429548, transcript variant X2
uncharacterized LOC124429548, transcript variant X1
lateral signaling target protein 2 homolog
CDK5 regulatory subunit-associated protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
WD repeat-containing protein 38-like, transcript variant X5
WD repeat-containing protein 38-like, transcript variant X3
WD repeat-containing protein 38-like isoform X5
WD repeat-containing protein 38-like isoform X3
WD repeat-containing protein 38-like, transcript variant X4
WD repeat-containing protein 38-like, transcript variant X1
WD repeat-containing protein 38-like, transcript variant X2
WD repeat-containing protein 38-like isoform X2
COMPASS-like H3K4 histone methylase component WDR5A isoform X4
WD repeat-containing protein 38-like isoform X1
arginine-hydroxylase NDUFAF5, mitochondrial
ubiquitin-fold modifier-conjugating enzyme 1
mesencephalic astrocyte-derived neurotrophic factor homolog
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
probable methyltransferase TARBP1, transcript variant X2
probable methyltransferase TARBP1, transcript variant X1
probable methyltransferase TARBP1 isoform X2
probable methyltransferase TARBP1 isoform X1
probable methyltransferase TARBP1, transcript variant X3
probable methyltransferase TARBP1 isoform X3
probable tRNA(His) guanylyltransferase, transcript variant X2
probable tRNA(His) guanylyltransferase, transcript variant X1
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X2
tubulin-specific chaperone C, transcript variant X2
tubulin-specific chaperone C, transcript variant X1
putative sodium-dependent multivitamin transporter, transcript variant X4
putative sodium-dependent multivitamin transporter, transcript variant X6
putative sodium-dependent multivitamin transporter, transcript variant X3
putative sodium-dependent multivitamin transporter, transcript variant X2
putative sodium-dependent multivitamin transporter, transcript variant X1
putative sodium-dependent multivitamin transporter, transcript variant X5
putative sodium-dependent multivitamin transporter isoform X1
putative sodium-dependent multivitamin transporter isoform X2
galactose mutarotase, transcript variant X3
galactose mutarotase, transcript variant X1
galactose mutarotase, transcript variant X2
choline/ethanolamine kinase, transcript variant X2
choline/ethanolamine kinase, transcript variant X3
choline/ethanolamine kinase, transcript variant X7
choline/ethanolamine kinase, transcript variant X1
choline/ethanolamine kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
choline/ethanolamine kinase, transcript variant X5
choline/ethanolamine kinase, transcript variant X4
uncharacterized protein DDB_G0283697-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
palmitoyltransferase app, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
palmitoyltransferase app, transcript variant X1
palmitoyltransferase ZDHHC18-A isoform X1
zinc finger protein 615, transcript variant X5
zinc finger protein 615, transcript variant X1
zinc finger protein 615, transcript variant X2
zinc finger protein 615, transcript variant X6
zinc finger protein 615, transcript variant X4
zinc finger protein 615, transcript variant X7
zinc finger protein 615, transcript variant X3
protein painting of fourth, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein painting of fourth, transcript variant X2
probable medium-chain specific acyl-CoA dehydrogenase, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nuclear hormone receptor FTZ-F1
glycine cleavage system H protein, transcript variant X2
glycine cleavage system H protein, transcript variant X1
protein arginine N-methyltransferase 5, transcript variant X1
protein arginine N-methyltransferase 5, transcript variant X2
eukaryotic translation initiation factor 4H-like, transcript variant X1
eukaryotic translation initiation factor 4H-like, transcript variant X2
eukaryotic translation initiation factor 4H-like isoform X1
eukaryotic translation initiation factor 4H-like isoform X2
PHD finger-like domain-containing protein 5A
COORDINATES: nucleotide motif:Rfam:12.0:RF00291
TRPL translocation defect protein 14, transcript variant X10
TRPL translocation defect protein 14 isoform X8
TRPL translocation defect protein 14, transcript variant X2
TRPL translocation defect protein 14, transcript variant X1
TRPL translocation defect protein 14, transcript variant X3
TRPL translocation defect protein 14, transcript variant X8
TRPL translocation defect protein 14, transcript variant X4
TRPL translocation defect protein 14, transcript variant X6
TRPL translocation defect protein 14, transcript variant X9
TRPL translocation defect protein 14, transcript variant X7
TRPL translocation defect protein 14, transcript variant X5
TRPL translocation defect protein 14 isoform X4
TRPL translocation defect protein 14 isoform X2
TRPL translocation defect protein 14 isoform X3
TRPL translocation defect protein 14 isoform X1
TRPL translocation defect protein 14 isoform X6
TRPL translocation defect protein 14 isoform X5
TRPL translocation defect protein 14 isoform X7
kelch domain-containing protein 10 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
kelch domain-containing protein 10 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
kelch domain-containing protein 10 homolog
RWD domain-containing protein 4, transcript variant X1
RWD domain-containing protein 4, transcript variant X3
RWD domain-containing protein 4, transcript variant X2
RWD domain-containing protein 4, transcript variant X5
RWD domain-containing protein 4, transcript variant X4
RUS family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RUS family member 1, transcript variant X1
RUS family member 1, transcript variant X7
RUS family member 1, transcript variant X5
RUS family member 1, transcript variant X4
RUS family member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RUS family member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TNF receptor-associated factor 4, transcript variant X5
TNF receptor-associated factor 4, transcript variant X4
TNF receptor-associated factor 4, transcript variant X3
TNF receptor-associated factor 4, transcript variant X1
TNF receptor-associated factor 4 isoform X1
TNF receptor-associated factor 4, transcript variant X2
TNF receptor-associated factor 4, transcript variant X6
TNF receptor-associated factor 4 isoform X2
TNF receptor-associated factor 4 isoform X3
probable DNA replication complex GINS protein PSF2
adenosine receptor A3-like, transcript variant X2
adenosine receptor A3-like, transcript variant X1
5-hydroxytryptamine receptor 1D-like isoform X1
sphingomyelin phosphodiesterase 4, transcript variant X6
sphingomyelin phosphodiesterase 4, transcript variant X2
sphingomyelin phosphodiesterase 4, transcript variant X5
sphingomyelin phosphodiesterase 4, transcript variant X3
sphingomyelin phosphodiesterase 4, transcript variant X4
sphingomyelin phosphodiesterase 4, transcript variant X1
sphingomyelin phosphodiesterase 4 isoform X6
sphingomyelin phosphodiesterase 4 isoform X2
sphingomyelin phosphodiesterase 4 isoform X5
sphingomyelin phosphodiesterase 4 isoform X3
sphingomyelin phosphodiesterase 4 isoform X4
sphingomyelin phosphodiesterase 4 isoform X1
solute carrier family 23 member 1, transcript variant X3
solute carrier family 23 member 1, transcript variant X2
solute carrier family 23 member 1, transcript variant X1
nuclear cap-binding protein subunit 3-like
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X7
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X3
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X5
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X6
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X9
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X8
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X4
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X10
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like
low density lipoprotein receptor adapter protein 1-like, transcript variant X2
low density lipoprotein receptor adapter protein 1-like, transcript variant X1
low density lipoprotein receptor adapter protein 1-like isoform X2
low density lipoprotein receptor adapter protein 1-like isoform X1
transmembrane protein 43 homolog, transcript variant X3
transmembrane protein 43 homolog, transcript variant X2
transmembrane protein 43 homolog, transcript variant X1
transmembrane protein 43 homolog isoform X2
transmembrane protein 43 homolog isoform X1
transmembrane protein 43 homolog isoform X3
thiamine transporter 2-like, transcript variant X2
thiamine transporter 2-like, transcript variant X1
serine protease inhibitor 88Ea-like, transcript variant X1
serine protease inhibitor 88Ea-like, transcript variant X2
serine protease inhibitor 88Ea-like isoform X1
serine protease inhibitor 88Ea-like, transcript variant X3
serine protease inhibitor 88Ea-like isoform X2
serine protease inhibitor 88Ea-like, transcript variant X4
serine protease inhibitor 88Ea-like isoform X3
mitochondrial import inner membrane translocase subunit Tim22
D-glucuronyl C5-epimerase B, transcript variant X1
D-glucuronyl C5-epimerase B, transcript variant X2
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, transcript variant X2
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, transcript variant X1
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
protein phosphatase 1 regulatory subunit 7-like, transcript variant X3
protein phosphatase 1 regulatory subunit 7-like, transcript variant X2
protein phosphatase 1 regulatory subunit 7-like, transcript variant X1
protein phosphatase 1 regulatory subunit 7-like isoform X3
protein phosphatase 1 regulatory subunit 7-like isoform X2
protein phosphatase 1 regulatory subunit 7-like isoform X1
zinc finger CCCH domain-containing protein 13-like, transcript variant X3
zinc finger CCCH domain-containing protein 13-like, transcript variant X2
zinc finger CCCH domain-containing protein 13-like, transcript variant X4
zinc finger CCCH domain-containing protein 13-like, transcript variant X1
zinc finger CCCH domain-containing protein 13-like
SET domain-containing protein SmydA-8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein eyes shut, transcript variant X1
protein eyes shut, transcript variant X3
protein eyes shut, transcript variant X2
protein eyes shut, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein eyes shut, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X1
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X2
ATP synthase mitochondrial F1 complex assembly factor 2
thioredoxin reductase-like selenoprotein T homolog CG3887
zinc finger and SCAN domain-containing protein 2-like, transcript variant X1
zinc finger and SCAN domain-containing protein 2-like isoform X1
zinc finger and SCAN domain-containing protein 2-like, transcript variant X2
zinc finger and SCAN domain-containing protein 2-like, transcript variant X3
zinc finger and SCAN domain-containing protein 2-like isoform X2
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X1
TP53-regulated inhibitor of apoptosis 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X6
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X9
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X11
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X4
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X7
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X8
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X2
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X3
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X5
TP53-regulated inhibitor of apoptosis 1-like isoform X2
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X10
TP53-regulated inhibitor of apoptosis 1-like isoform X3
cyclic AMP-dependent transcription factor ATF-6 alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein SMG7-like, transcript variant X1
protein SMG7-like, transcript variant X2
transcription factor A, mitochondrial, transcript variant X2
transcription factor A, mitochondrial, transcript variant X1
CCR4-NOT transcription complex subunit 3
probable ATP-dependent RNA helicase DDX47
leucine-rich repeat-containing protein 28-like, transcript variant X1
leucine-rich repeat-containing protein 28-like, transcript variant X2
leucine-rich repeat-containing protein 28-like, transcript variant X3
leucine-rich repeat-containing protein 28-like, transcript variant X4
leucine-rich repeat-containing protein 28-like isoform X2
leucine-rich repeat-containing protein 28-like isoform X1
leucine-rich repeat-containing protein 28-like isoform X3
corrinoid adenosyltransferase-like, transcript variant X2
corrinoid adenosyltransferase-like, transcript variant X1
protein phosphatase Slingshot homolog 2, transcript variant X2
protein phosphatase Slingshot homolog 2 isoform X2
protein phosphatase Slingshot homolog 2, transcript variant X1
protein phosphatase Slingshot homolog 2 isoform X1
protein phosphatase Slingshot homolog 2, transcript variant X3
protein phosphatase Slingshot homolog 2 isoform X3
protein phosphatase Slingshot homolog 2, transcript variant X4
serine-rich adhesin for platelets isoform X4
protein phosphatase Slingshot homolog 2, transcript variant X5
serine-rich adhesin for platelets isoform X5
DNA topoisomerase 2-binding protein 1, transcript variant X1
DNA topoisomerase 2-binding protein 1, transcript variant X3
DNA topoisomerase 2-binding protein 1, transcript variant X2
DNA topoisomerase 2-binding protein 1 isoform X1
DNA topoisomerase 2-binding protein 1 isoform X3
DNA topoisomerase 2-binding protein 1 isoform X2
Y+L amino acid transporter 2, transcript variant X2
Y+L amino acid transporter 2, transcript variant X3
Y+L amino acid transporter 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SNF-related serine/threonine-protein kinase, transcript variant X2
SNF-related serine/threonine-protein kinase, transcript variant X4
SNF-related serine/threonine-protein kinase, transcript variant X1
SNF-related serine/threonine-protein kinase, transcript variant X3
SNF-related serine/threonine-protein kinase isoform X1
maternal embryonic leucine zipper kinase isoform X2
choline transporter-like protein 1, transcript variant X2
choline transporter-like protein 1, transcript variant X5
choline transporter-like protein 1, transcript variant X3
choline transporter-like protein 1, transcript variant X4
choline transporter-like protein 1, transcript variant X1
choline transporter-like protein 1 isoform X2
choline transporter-like protein 1 isoform X1
choline transporter-like protein 1 isoform X3
probable Na(+)/H(+) antiporter nhx-9, transcript variant X1
probable Na(+)/H(+) antiporter nhx-9, transcript variant X4
probable Na(+)/H(+) antiporter nhx-9, transcript variant X3
probable Na(+)/H(+) antiporter nhx-9, transcript variant X5
probable Na(+)/H(+) antiporter nhx-9, transcript variant X2
probable Na(+)/H(+) antiporter nhx-9 isoform X1
probable Na(+)/H(+) antiporter nhx-9 isoform X3
probable Na(+)/H(+) antiporter nhx-9 isoform X4
protein lifeguard 1, transcript variant X2
protein lifeguard 1, transcript variant X1
U3 small nucleolar RNA-associated protein 4 homolog
uncharacterized LOC124429463, transcript variant X1
uncharacterized LOC124429463, transcript variant X3
uncharacterized LOC124429463, transcript variant X5
uncharacterized LOC124429463, transcript variant X4
uncharacterized LOC124429463, transcript variant X2
uncharacterized LOC124429465, transcript variant X3
uncharacterized LOC124429465, transcript variant X1
uncharacterized LOC124429465, transcript variant X2
uncharacterized LOC124429468, transcript variant X2
uncharacterized LOC124429468, transcript variant X1
uncharacterized LOC124429456, transcript variant X1
uncharacterized protein LOC124429456 isoform X1
uncharacterized LOC124429456, transcript variant X2
uncharacterized protein LOC124429456 isoform X2
GATA zinc finger domain-containing protein 11-like
tyrosine-protein kinase Src64B, transcript variant X1
tyrosine-protein kinase Src64B, transcript variant X3
tyrosine-protein kinase Src64B, transcript variant X2
tyrosine-protein kinase Src64B isoform X2
tyrosine-protein kinase Src64B isoform X1
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 2
cytochrome c1, heme protein, mitochondrial
protein LSM14 homolog B-A, transcript variant X1
protein LSM14 homolog B-A, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X4
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X4
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like isoform X1
zinc finger protein 511, transcript variant X4
zinc finger protein 511, transcript variant X1
zinc finger protein 511, transcript variant X3
zinc finger protein 511, transcript variant X2
40S ribosomal protein S12, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
40S ribosomal protein S12, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transcription factor VBP-like isoform X1
40S ribosomal protein S12, mitochondrial-like, transcript variant X6
40S ribosomal protein S12, mitochondrial-like, transcript variant X7
40S ribosomal protein S12, mitochondrial-like, transcript variant X3
40S ribosomal protein S12, mitochondrial-like, transcript variant X4
40S ribosomal protein S12, mitochondrial-like, transcript variant X5
40S ribosomal protein S12, mitochondrial-like isoform X2
glycine-rich protein-like, transcript variant X4
glycine-rich protein-like, transcript variant X3
glycine-rich protein-like, transcript variant X1
glycine-rich protein-like, transcript variant X2
mitochondrial genome maintenance exonuclease 1-like
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase I
uncharacterized LOC124429434, transcript variant X7
uncharacterized LOC124429434, transcript variant X11
uncharacterized LOC124429434, transcript variant X3
uncharacterized LOC124429434, transcript variant X4
uncharacterized LOC124429434, transcript variant X1
uncharacterized LOC124429434, transcript variant X9
uncharacterized LOC124429434, transcript variant X10
uncharacterized LOC124429434, transcript variant X2
uncharacterized LOC124429434, transcript variant X8
uncharacterized LOC124429434, transcript variant X6
uncharacterized LOC124429434, transcript variant X5
uncharacterized protein LOC124429434 isoform X1
uncharacterized protein LOC124429434 isoform X2
uncharacterized protein LOC124429434 isoform X3
uncharacterized protein LOC124429434 isoform X4
uncharacterized protein LOC124429434 isoform X5
uncharacterized LOC124429434, transcript variant X12
uncharacterized protein LOC124429434 isoform X6
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X5
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X6
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X7
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like